SEC Form 4 · accession 0001209191-17-017513
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Schenkein
Director
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2017 | M | 5,000 | $8.1558 | A | 7,176 | D | |
| Common StockF1 | Mar 1, 2017 | S | 5,000 | $89.5265 | D | 2,176 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $8.1558 | Mar 1, 2017 | M | 5,000 | D | — | Apr 29, 2023 | Common Stock | 5,000 | 21,361 | D |
Explanation of responses
- F1The range in prices for the transaction reported on this line was $89.15 to $89.75. The average weighted price was $89.5265. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2This options vests annually over a three period beginning April 29, 2013.